1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, July 2017 (p2)

Biological Therapy Analysis & Statistics, July 2017 (p2)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

31-60 of about 1000 reports

Purchase Reports From Reputable Market Research Publishers

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H2 2017 Summary Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen ...

  • Industries : Pathology, Therapy, Cancer, Pharmaceutical, Biological Therapy
  • Countries : United States, World

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H2 2017 Summary Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Interleukin-7 receptor is a protein found ...

  • Industries : Pathology, Biological Therapy, Therapy
  • Countries : World, United States, Europe, France

Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Landscape, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3500
  • Industry report
  • July 2017
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2017

  • $ 3500
  • Company report
  • July 2017
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H2 2017 Summary According to the recently published report ’Granulocyte Macrophage ...

  • Industries : Therapy, Biological Therapy, Cancer, Pathology, Pharmaceutical
  • Countries : United States, World

Interleukin 1 Receptor Type 1 (CD121 Antigen Like Family Member A or Interleukin 1 Receptor Alpha or p80 or CD121a or IL1R1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Interleukin 1 Receptor Type 1 (CD121 Antigen Like Family Member A or Interleukin 1 Receptor Alpha or p80 or CD121a or IL1R1) - Pipeline Review, H1 2017 Summary According to the recently published report ...

  • Industries : Pathology, Therapy, Chronic Disease, Biological Therapy
  • Countries : World

LanC Like Protein 2 (Testis Specific Adriamycin Sensitivity Protein or G Protein Coupled Receptor 69B or GPR69B or LANCL2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

LanC Like Protein 2 (Testis Specific Adriamycin Sensitivity Protein or G Protein Coupled Receptor 69B or GPR69B or LANCL2) - Pipeline Review, H1 2017 Summary According to the recently published report ...

  • Industries : Chronic Disease, Pathology, In Vitro Diagnostics, Therapy
  • Countries : World

Cell Surface Marker Testing Market 2021: US, Europe (France, Germany, Italy, Spain, UK), Japan--Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 3500
  • Industry report
  • June 2017
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, Italy, United Kingdom, Japan

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) - Pipeline Review, H1 2017 Summary Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States

Dystrophin (DMD) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Dystrophin (DMD) - Pipeline Review, H1 2017 Summary According to the recently published report 'Dystrophin (DMD) - Pipeline Review, H1 2017'; Dystrophin (DMD) pipeline Target constitutes close to 26 molecules. ...

  • Industries : Mental Health, Therapy, Pharmaceutical, Pathology
  • Countries : United States

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H1 2017 Summary Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Frataxin is a protein ...

  • Industries : Therapy
  • Countries : World, United States

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein ...

  • Industries : Therapy
  • Countries : United States

Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H1 2017 Summary Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) pipeline Target constitutes close ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States

Interleukin 1 (IL1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Interleukin 1 (IL1) - Pipeline Review, H1 2017 Summary Interleukin 1 (IL1) pipeline Target constitutes close to 28 molecules. Out of which approximately 27 molecules are developed by companies and remaining ...

  • Industries : Therapy, Pathology, Cancer, Pharmaceutical
  • Countries : World, United States, Europe

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H1 2017 Summary According to the recently published report 'N Sulphoglucosamine ...

  • Industries : Therapy, Biological Therapy, Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : United States

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • June 2017
  • by Global Markets Direct

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2017 Summary Alpha L-Iduronidase (IDUA or EC 3.2.1.76) pipeline Target constitutes close to 9 molecules. Out of which approximately 7 molecules ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Pharmaceutical, Biotechnology, Biological Therapy
  • Countries : United States, World

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H1 2017 Summary Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States, World

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline Review, H1 2017 Summary According to the recently published ...

  • Industries : Cancer, Pathology, Biological Therapy, Therapy
  • Countries : United States, World

Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H1 2017

  • $ 3500
  • Company report
  • May 2017
  • by Global Markets Direct

Transforming Growth Factor Beta 2 (BSC1 Cell Growth Inhibitor or Cetermin or Glioblastoma Derived T Cell Suppressor Factor or Polyergin or TGFB2) - Pipeline Review, H1 2017 Summary According to the recently ...

  • Industries : Pathology, Therapy, Health Services, Cancer
  • Countries : World

Gene Therapy Ophthalmology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2017

  • $ 2950
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s report, “Gene Therapy Ophthalmology Insight - Pipeline Assessment, Market Trend, Technology and Competitive Landscape, 2017” emphasizes on the currently under development Gene Therapy ...

  • Industries : Biological Therapy

Natural Killer Cells -Competitive Landscape, Technology and Pipeline Analysis, 2017

  • $ 2750
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s, “Natural Killer Cells- Competitive Landscape, Pipeline and Market Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of ...

  • Industries : Therapy, Biological Therapy

Blood Purification Equipment - Medical Devices Pipeline Assessment, 2017

  • $ 2500
  • Industry report
  • August 2017
  • by GlobalData

Blood Purification Equipment - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Blood Purification Equipment - Medical Devices Pipeline Assessment, 2017" ...

  • Industries : Healthcare, Pharmaceutical, Pathology, Drug Discovery and Development, Health Services
  • Countries : United States

Cystic Fibrosis Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Cystic Fibrosis Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Cystic Fibrosis Global Clinical Trials Review, H2, 2017" provides an overview of Cystic Fibrosis ...

  • Industries : Pharmaceutical, Drug Discovery and Development, Pathology
  • Countries : World, United States

Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H2, ...

  • Industries : Therapy, Pathology, Pharmaceutical, Drug Discovery and Development, Healthcare
  • Countries : World

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : World

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2017" provides ...

  • Industries : Pathology, Therapy, Healthcare, Pharmaceutical, Drug Discovery and Development
  • Countries : World

Critical Limb Ischemia Global Clinical Trials Review, H2, 2017

  • $ 2500
  • Industry report
  • July 2017
  • by GlobalData

Critical Limb Ischemia Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Critical Limb Ischemia Global Clinical Trials Review, H2, 2017" provides an overview of Critical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy, Health Services
  • Countries : World

Pancreatic Cancer - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2017, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus ...

  • Industries : Pathology, Healthcare
  • Countries : United States

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) - Pipeline Review, ...

  • Industries : Cancer, Pathology, Healthcare
  • Countries : United States

Ovarian Cancer - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.